New locus for skin intrinsic fluorescence in type 1 diabetes also associated with blood and skin glycated proteins
Skin fluorescence (SF) noninvasively measures advanced glycation end products (AGEs) in the skin and is a risk indicator for diabetes complications. N-acetyltransferase 2 (NAT2) is the only known locus influencing SF. We aimed to identify additional genetic loci influencing SF in type 1 diabetes (T1D) through a meta-analysis of genomewide association studies (N = 1,359) including Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) and Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). A locus on chromosome 1, rs7533564 (P = 1.9 × 10-9), was associated with skin intrinsic fluorescence measured by SCOUT DS (excitation 375 nm, emission 435-655 nm), which remained significant after adjustment for time-weighted HbA1c (P = 1.7 × 10-8). rs7533564 was associated with mean HbA1c in meta-analysis (P = 0.0225), mean glycated albumin (P = 0.0029), and glyoxal hydroimidazolones (P = 0.049), an AGE measured in skin biopsy collagen, in DCCT. rs7533564 was not associated with diabetes complications in DCCT/EDIC or with SF in subjects without diabetes (nondiabetic [ND]) (N = 8,721). In conclusion, we identified a new locus associated with SF in T1D subjects that did not show similar effect in ND subjects, suggesting a diabetes-specific effect. This association needs to be investigated in type 2 diabetes.
Roshandel, D., Klein, R., Klein, B., Wolffenbuttel, B., Van Der Klauw, M., Van Vliet-Ostaptchouk, J., Atzmon, G., Ben-Avraham, D., Crandall, J., Barzilai, N., Bull, S., Canty, A., Hosseini, S., Hiraki, L., Maynard, J., Sell, D., Monnier, V., Cleary, P., Braffett, B., & Paterson, A. (2016). New locus for skin intrinsic fluorescence in type 1 diabetes also associated with blood and skin glycated proteins. Diabetes, 65 (7). http://dx.doi.org/10.2337/db15-1484